Can be great, but be careful - Director Quality Merck Employee Review

3.0
Feb 6, 2024
Recommend
CEO approval
Business outlook

Pros

Great people, good opportunities to volunteer.

Cons

Different divisions are like entirely different companies; some management is amazing, but some are brutal (severely incompetent with big egos, but somehow protected). With recent policy changes and layoff strategy, pretty clear that in 2024, they’re focused on cutting cost and don’t have a lot of value for their more experienced employees.

Explore other reviews about Merck

5.0
Jun 30, 2026
Recommend
CEO approval
Business outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
Jun 30, 2026
Recommend
CEO approval
Business outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All